MARKET WIRE NEWS

Protalix BioTherapeutics, Inc. (PLX) Q1 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-05-09 16:12:51 ET

Protalix BioTherapeutics, Inc. (PLX)

Q1 2025 Earnings Conference Call

May 9, 2025 8:30 AM ET

Company Participants

Mike Moyer – Investor Relations

Dror Bashan – President and Chief Executive Officer

Eyal Rubin – Senior Vice President and Chief Financial Officer

Conference Call Participants

John Vandermosten – Zacks

Presentation

Operator

Good morning, ladies and gentlemen, and welcome to the Protalix BioTherapeutics First Quarter 2025 Financial and Business Results Conference Call. As a reminder, this conference is being recorded.

I will now turn the conference over to our host, Mike Moyer of LifeSci Advisors, Investor Relations for Protalix. Thank you. Please go ahead.

Mike Moyer

Thank you, operator, and welcome to the Protalix BioTherapeutics first quarter 2025 financial results and business update conference call. With me today are Dror Bashan, President and CEO of Protalix; and Eyal Rubin, Senior Vice President and Chief Financial Officer....

Read the full article on Seeking Alpha

For further details see:

Protalix BioTherapeutics, Inc. (PLX) Q1 2025 Earnings Call Transcript
Protalix BioTherapeutics Inc.

NASDAQ: PLX

PLX Trading

3.7% G/L:

$2.94 Last:

365,304 Volume:

$2.88 Open:

mwn-link-x Ad 300

PLX Latest News

PLX Stock Data

$215,126,659
70,448,955
0.23%
25
N/A
Biotechnology & Life Sciences
Healthcare
US
Hackensack

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App